Celadon
CEL.LCeladon Pharmaceuticals Plc Price (CEL.L)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
61,893,906
(8.0266)%Cash Flow Statement
Celadon Pharmaceuticals PlcCurrency: GBp
| YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -151,697.00
+0% |
-1,059,793.00
+599% |
-4,783,000.00
+351% |
-17,411,000.00
+264% |
-7,140,000.00
-59% |
||||||||||||||
| Depreciation And Amortiz... | 33.48k | 160.85k | 319.00k | 466.00k | 534.00k | ||||||||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 7.31M | 285.00k | ||||||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | -1,080.00 | 5.89k | -2,135,171.00 | -985,000.00 | 108.00k | ||||||||||||||
| Accounts Payables | 0.00 | 0.00 | 0.00 | 355.00k | -250,000.00 | ||||||||||||||
| Inventory | 0.00 | 0.00 | 0.00 | -18,000.00 | -6,000.00 | ||||||||||||||
| Other Working Capital | 32.94k | 477.06k | 2.16M | 0.00 | 0.00 | ||||||||||||||
| Other Non-Cash Items | 121.27k | 338.42k | 1.29M | 4.18M | 497.00k | ||||||||||||||
| Net Cash Provided By Op... | 1.98k
+0% |
-77,574.00
-4,016% |
-3,148,000.00
+3,958% |
-6,100,000.00
+94% |
-5,972,000.00
-2% |
||||||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | 0.00 | -708,243.00 | -542,000.00 | -2,086,000.00 | -341,000.00 | ||||||||||||||
| Acquisitions Net | 0.00 | 11.21k | -500,000.00 | 3.49M | 0.00 | ||||||||||||||
| Purchases Of Investments | 0.00 | 0.00 | -200,000.00 | -18,000.00 | 0.00 | ||||||||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 700.00k | -3,475,999.00 | 0.00 | ||||||||||||||
| Other Investing Activities | 0.00 | 0.00 | -700,000.00 | 3.48M | 0.00 | ||||||||||||||
| Net Cash Used For Inv... | 0.00
+0% |
-697,033.00
+0% |
-1,242,000.00
+78% |
1.39M
-212% |
-341,000.00
-125% |
||||||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | 50.00k | 5.40M | -1,511,000.00 | -1,000.00 | ||||||||||||||
| Common Stock Issued | 5.82M | 1.02M | 389.00k | 7.49M | 2.98M | ||||||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Other Financing Activities | 5.82M | 0.00 | 2.12M | -32,000.00 | -464,000.00 | ||||||||||||||
| Net Cash Used/Provide... | 5.82M
+0% |
1.07M
-82% |
7.91M
+638% |
5.95M
-25% |
2.51M
-58% |
||||||||||||||
| Effect Of Forex Changes... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Net Change In Cash | 5.82M | 297.99k | 3.52M | 1.24M | -3,802,000.00 | ||||||||||||||
| Cash At Beginning Of Per... | -176,030.00 | 1.49k | 300.00k | 3.82M | 5.06M | ||||||||||||||
| Cash At End Of Period | 5.65M | 299.48k | 3.82M | 5.06M | 1.26M | ||||||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 1.98k | -77,574.00 | -3,148,000.00 | -6,100,000.00 | -5,972,000.00 | ||||||||||||||
| Capital Expenditure | 0.00 | -708,243.00 | -542,000.00 | -2,086,000.00 | -341,000.00 | ||||||||||||||
| Free Cash Flow | 1.98k
+0% |
-785,817.00
-39,768% |
-3,690,000.00
+370% |
-8,186,000.00
+122% |
-6,313,000.00
-23% |
||||||||||||||